Brief: Wanbury Ltd Launches Coriminic CPM Drops For Pediatric Use
24/03/2026 07:33
March 24 (Reuters) - Wanbury Ltd WANB.NS: WANBURY LTD - LAUNCHES CORIMINIC CPM DROPS FOR PEDIATRIC USE WANBURY LTD - LAUNCHES CORIMINIC NS NASAL DROPS FOR CHILDREN Source text: ID:nNSELc6Vx Further company coverage: WANB.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wanbury
See all newsBrief: Wanbury Says Tanuku API Site Completes TGA Quality Inspection
Brief: Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients
Brief: Wanbury Says Patalganga Site Has Completed Korea FDA Regulatory Inspection Successfully
Brief: Wanbury Ltd Launches Coriminic CPM Drops For Pediatric Use
Brief: Wanbury Receives Sertraline Form II Approval From Anvisa, Brazil